Featured Image

Sarcopenia as a specific condition was initially identified in 1989. Originally, it referred to the loss of muscle mass that occurs with age, and was seen as a characteristic state almost universal with aging. Over time clinical perspectives on sarcopenia have evolved and sarcopenia has now come to be defined as a clinically significant disorder based on distinct findings and functional issues. There is wide conceptual agreement on the base definition of sarcopenia but variations still exist with specific cut-points. Join this one-hour webinar to hear from leaders of national and international efforts to reach agreement on appropriate cut-points for the condition.


Francesco Landi, M.D., Ph.D. (Link)

Associate Professor of Internal Medicine and Geriatrics
Catholic University of Sacred Heart, Rome, Italy

Shalander Bashin, M.D. (Link)

Director, Research Program in Men’s Health: Aging & Metabolism
Director, Claude D. Pepper Older Americans Independence Center for Function Promoting Therapies
Brigham and Women’s Hospital
Harvard Medical School

Cynthia A. Bens (Moderator)

Vice President of Public Policy, Alliance for Aging Research
Executive Director, Aging in Motion (AIM)